BetterLife Pharma FCF per Share
Free Cash Flow per Share of BetterLife Pharma (BETR.CN) as of Aug 14, 2026.
Get this data via API
Financial Data API
FCF per Share
0.00CAD
Last updated:
Free Cash Flow per Share of BetterLife Pharma is 2026 0.00 CAD. Free Cash Flow per Share of BetterLife Pharma was 2025 0.00 CAD. It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API
BetterLife Pharma Stock analysis
What does BetterLife Pharma do? BetterLife Pharma Inc is an innovative company specializing in the development and marketing of therapeutic solutions. The company was founded in 2016 and is headquartered in Vancouver, Canada. It is a publicly traded company listed on the Canadian stock exchange TSX Venture Exchange under the ticker symbol BETR and on the Frankfurt stock exchange under the ticker symbol NPA.
BetterLife's mission is to research and develop life-changing medications that improve patients' lives while increasing shareholder value. The company relies on a combination of scientific knowledge and innovative technology to develop effective and safe therapies.
BetterLife Pharma is divided into the biotechnology and healthcare sectors. In biotechnology research, the company focuses on developing novel medications for the treatment of conditions such as depression, anxiety, pain, and autoimmune diseases. In healthcare, the company offers a range of services including clinical trials and consulting for healthcare organizations and companies.
An important product of BetterLife is the medication TD-0148A, which is developed for the treatment of depression. It aims to regulate neurotransmitters in the brain to improve the mood of depressive patients. The medication is currently in clinical phase II and has the potential to be used by millions of patients worldwide.
Another important product of BetterLife is the platform technology Cyclica, which allows companies and researchers to make better predictions about drug effects. Cyclica utilizes artificial intelligence and machine learning to gather and analyze a wide range of information about drugs and their mechanisms of action. The technology has already gained global recognition and is used by prestigious institutions such as Harvard Medical School.
BetterLife's business model is based on collaboration with other companies, researchers, and healthcare experts. The company aims to form partnerships with companies in the biotech and pharmaceutical industries to further develop and market its technologies and products.
In recent years, BetterLife Pharma Inc has made significant progress and achieved impressive milestones. The company has conducted several successful financing rounds to fund its research and development. It has formed strategic alliances with key players in the industry and promoted its technologies and products worldwide.
BetterLife Pharma represents innovation, excellence, and excellence in research and development. The company has the potential to improve the lives of millions of people worldwide while providing attractive returns for its investors. BetterLife Pharma is one of the most popular companies on Eulerpool.
Frequently Asked Questions about BetterLife Pharma stock
On Eulerpool you can find the complete historical development of Free Cash Flow per Share BetterLife Pharma since 2006 – with annual values, charts, and detailed analysis.
FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.
Access this data via the Eulerpool API
Cash Flow — BetterLife Pharma
Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A
All Key Metrics — BetterLife Pharma
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth